Parkinson’s disease is associated with abnormal beta wave activity in the subthalamic nucleus (STN), but a direct connection between this activity and movement difficulties has not yet been established.
A study group at Osaka University developed a neurofeedback system which enables patients with Parkinson’s disease to voluntarily control beta wave activity in their deep brain associated with symptoms of the disorder. The group demonstrated that the patients can control these beta waves voluntary; however, it remains to be determined whether such a system can provide symptom relief. The group’s research results were published in eNeuro.
